BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 308716)

  • 21. Techniques used to define human MHC antigens: serology.
    Dyer PA; Martin S
    Immunol Lett; 1991 Jul; 29(1-2):15-21. PubMed ID: 1916915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human histocompatibility complex: a review for the hematologist.
    Miller WV
    Prog Hematol; 1977; 10():173-91. PubMed ID: 337359
    [No Abstract]   [Full Text] [Related]  

  • 23. Antigens in human monocytes. III. Use of monocytes in typing for HLA-D related (DR) antigens.
    Colbaugh P; Stastny P
    Transplant Proc; 1978 Dec; 10(4):871-4. PubMed ID: 310596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
    Wong DM; Kumar R; Mittal KK
    Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Ia antigens in severe combined immunodeficiency disease (SCID).
    Falk JA; Gelfand E; Ing P; Dosch M; Falk RE
    Transplant Proc; 1979 Mar; 11(1):767-9. PubMed ID: 109971
    [No Abstract]   [Full Text] [Related]  

  • 26. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 27. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of a polymorphic monocyte antigen in HLA.
    van Leeuwen A; Termijtelen A; Shaw S; van Rood JJ
    Nature; 1982 Aug; 298(5874):565-7. PubMed ID: 6980374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of a non-HLA-ABC antigen present on B and T lymphocytes and monocytes only detectable with the indirect immunofluorescence test.
    Décary F; Verheugt FW; van Helden-Henningheim L; von Riesz E; Schreuder-van Gelder R; von dem Borne AE; Engelfriet CP
    Vox Sang; 1979; 36(3):150-8. PubMed ID: 88812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.
    Winchester RJ; Wernet P; Kunkel HG; Dupont B; Jersild C; Fu SM
    J Exp Med; 1975 Apr; 141(4):924-9. PubMed ID: 47890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.
    Humphreys RE; McCune JM; Chess L; Herrman HC; Malenka DJ; Mann DL; Parham P; Schlossman SF; Strominger JL
    J Exp Med; 1976 Jul; 144(1):98-112. PubMed ID: 58959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human endothelial cell antigens: molecular independence from HLA and expression in blood monocytes.
    Moraes JR; Stastny P
    Transplant Proc; 1977 Mar; 9(1):605-7. PubMed ID: 325796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 34. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
    Horwitz DA; Garrett MA
    J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new strategy to improve kidney graft survival: the induction of CML nonresponsiveness.
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Gabb BW
    Transplant Proc; 1979 Mar; 11(1):736-42. PubMed ID: 88102
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties.
    Winchester RJ; Wang CY; Halper J; Hoffman T
    Scand J Immunol; 1976; 5(6-7):745-57. PubMed ID: 62389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
    Hirschberg H; Moen T; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
    [No Abstract]   [Full Text] [Related]  

  • 38. B- and T-cell-specific alloantigens in man.
    Albert ED; Andreas A; McNicholas A; Scholtz S; Kuntz B
    Scand J Immunol; 1977; 6(5):427-30. PubMed ID: 70060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR typing by radioimmunoassay.
    Tosi R; Tanigaki N; Centis D; Rossi PL; Alfano G; Ferrara GB; Pressman D
    Transplantation; 1980 Apr; 29(4):302-5. PubMed ID: 7368279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.